Flu vaccine

Improved Influenza vaccine

Improved influenza vaccine using novel vaccine adjuvant

R&D Goals

Influenza vaccine effectiveness can vary from year to year and among different age and risk groups.

Adjuvants can be added vaccines to enhance immune response. Adjuvants also can reduce the amount of antigen, which can allow for greater supplies of vaccine, especially outbreak.

By formulating influenza vaccine with adjuvant L-pampo, we can improve influenza vaccine efficacy, especially for older adults with weaker immune system and can prolong the duration of the protection.